Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1 H -imidazo[4,5- f ][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231

Rishav Das, Shanooja Shanavas, Utpal Das, Rajesh Kushwaha, Rinku Chakrabarty, Samya Banerjee, Debajit Chaudhury, S. Shenoy P, Bipasha Bose, Priyankar Paira

Open source

DOI: 10.1021/acs.jmedchem.5c02400
Published: 2025-12-07
Container: Journal of Medicinal Chemistry
Publisher: American Chemical Society (ACS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.5c02400,
  title = {Turning the
Spotlight
Away from PDT: Chemodynamic
Dominance of 2-(2-Bromopyridin-4-yl)-1
                    <i>H</i>
                    -imidazo[4,5-
                    <i>f</i>
                    ][1,10]phenanthroline
Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231},
  author = {Rishav Das and Shanooja Shanavas and Utpal Das and Rajesh Kushwaha and Rinku Chakrabarty and Samya Banerjee and Debajit Chaudhury and S. Shenoy P and Bipasha Bose and Priyankar Paira},
  year = {2025},
  journal = {Journal of Medicinal Chemistry},
  doi = {10.1021/acs.jmedchem.5c02400},
  url = {https://doi.org/10.1021/acs.jmedchem.5c02400}
}

RIS

TY  - JOUR
TI  - Turning the
Spotlight
Away from PDT: Chemodynamic
Dominance of 2-(2-Bromopyridin-4-yl)-1
                    <i>H</i>
                    -imidazo[4,5-
                    <i>f</i>
                    ][1,10]phenanthroline
Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231
AU  - Rishav Das
AU  - Shanooja Shanavas
AU  - Utpal Das
AU  - Rajesh Kushwaha
AU  - Rinku Chakrabarty
AU  - Samya Banerjee
AU  - Debajit Chaudhury
AU  - S. Shenoy P
AU  - Bipasha Bose
AU  - Priyankar Paira
PY  - 2025
JO  - Journal of Medicinal Chemistry
DO  - 10.1021/acs.jmedchem.5c02400
UR  - https://doi.org/10.1021/acs.jmedchem.5c02400
ER  -

APA

Das, R., Shanavas, S., Das, U., Kushwaha, R., Chakrabarty, R., Banerjee, S., Chaudhury, D., P, S. S., Bose, B., & Paira, P. (2025). Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1 H -imidazo[4,5- f ][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02400

Source records

crossref · retrieved 2026-09-26T10:14:53.069Z

Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1 <i>H</i> -imidazo[4,5- <i>f</i> ][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records